Dr. Reddy's launches generic version of Plavix

HYDERABAD, India — Generic drug maker Dr. Reddy's Labs has launched a generic version of a drug used to prevent clotting of the blood.



Dr. Reddy's announced Friday the launch of clopidogrel tablets in the 75-mg and 300-mg strengths. The drug is a generic version of Plavix, made by Bristol-Myers Squibb and Sanofi. As one of the first companies to submit a completed regulatory application for the 300 mg strength of the drug, Dr. Reddy's received 180 days of market exclusivity for it.



Plavix had sales of $6.74 billion during the 12-month period ended in March, according to IMS Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.